Literature DB >> 9246215

Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls.

O Molberg1, K Kett, H Scott, E Thorsby, L M Sollid, K E Lundin.   

Abstract

The authors have analysed gliadin specific, CD4+ T cells isolated from small intestinal biopsies of 23 adult coeliac disease patients (20 on a gluten-free diet and three untreated) and nine control patients. The biopsies were stimulated ex vivo with a peptic/tryptic digest of gliadin for 24 h, and activated T cells were positively selected with paramagnetic beads coated with an antibody against the interleukin-2 receptor. The T cells were expanded and tested for gliadin reactivity and HLA restriction. Gliadin specific, polyclonal T cell lines were recovered from biopsies of all 23 patients. Inhibition studies of T cell lines from 21 patients with anti-HLA monoclonal antibodies indicated predominant presentation of the gliadin antigen by HLA-DQ2 in T cell lines from 11 patients (lines from seven patients with complete MoAb inhibition, the remaining with incomplete inhibition) and incomplete inhibition by HLA-DR3 in lines from three patients. Nine gliadin specific T cell clones from six patients were established; all of these were HLA-DQ2 restricted. Gliadin specific T cells were not found in biopsies from the non-coeliac controls. Our findings demonstrate that gliadin reactive T cells are commonly found in the intestinal mucosa of CD patients and they support the notion that the majority of T cells recognize gliadin peptide(s) when presented by the disease associated DQ2 molecules.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246215

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

1.  A novel and sensitive method for the detection of T cell stimulatory epitopes of alpha/beta- and gamma-gliadin.

Authors:  E H A Spaenij-Dekking; E M C Kooy-Winkelaar; W F Nieuwenhuizen; J W Drijfhout; F Koning
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Immunopathogenesis of celiac disease.

Authors:  Jason Tye-Din; Robert Anderson
Journal:  Curr Gastroenterol Rep       Date:  2008-10

3.  T cell proliferation, MHC class II restriction and cytokine products of gliadin-stimulated peripheral blood mononuclear cells (PBMC).

Authors:  J O'Keeffe; K Mills; J Jackson; C Feighery
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 4.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

Review 5.  Antigen presentation in celiac disease.

Authors:  Shuo-Wang Qiao; Ludvig M Sollid; Richard S Blumberg
Journal:  Curr Opin Immunol       Date:  2009-04-01       Impact factor: 7.486

6.  Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders.

Authors:  Anna Dahele; Marian C Aldhous; Kathleen Kingstone; Kennneth Humphreys; John Bode; Margaret McIntyre; Subrata Ghosh
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

Review 7.  The adaptive immune response in celiac disease.

Authors:  Shuo-Wang Qiao; Rasmus Iversen; Melinda Ráki; Ludvig M Sollid
Journal:  Semin Immunopathol       Date:  2012-04-26       Impact factor: 9.623

8.  The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.

Authors:  H Arentz-Hansen; R Körner; O Molberg; H Quarsten; W Vader; Y M Kooy; K E Lundin; F Koning; P Roepstorff; L M Sollid; S N McAdam
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

Review 9.  Immune development and intestinal microbiota in celiac disease.

Authors:  Tamara Pozo-Rubio; Marta Olivares; Esther Nova; Giada De Palma; Jorge R Mujico; Maria Desamparados Ferrer; Ascensión Marcos; Yolanda Sanz
Journal:  Clin Dev Immunol       Date:  2012-09-11

Review 10.  Celiac disease and autoimmune-associated conditions.

Authors:  Eugenia Lauret; Luis Rodrigo
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.